Login
Novartis erhöht nach erfolgreichem 2024 mittelfristige Prognose
Syngenta baut Standort Münchwilen mit 40 Millionen Franken aus
Schweizer Chemie- und Pharmaindustrie belegt Spitzenplatz bei...
Overview and position on antibiotic resistance
Action plan: One Health approach to combating antimicrobial resistance
Promoting research into new antibiotics - but how?
Containing resistances: Antibiotic monitoring in veterinary medicine
25 years of bilateral agreements: a model of success for Switzerland
Guest article Allnews: Director Stephan Mumenthaler
Overview and position on relations with the EU
Full association to Horizon Europe essential
Interview by NZZ: Matthias Leuenberger, President scienceindustries
30 Years EU Single Market: Significance for Switzerland
What happens after the failed negotiations on the (InstA)?
Science-based regulation for a sustainable future
PFAS regulation in Switzerland: Learning from European experiences
PFAS regulation in Switzerland: Not faster, but better
Differentiated view of "risk versus hazard"
Export bans: International solutions instead of solo national efforts